Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 11, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 16, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001437749-26-020703
Filed / recorded
Jun 16, 2026, 4:09 AM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
PUMA BIOTECHNOLOGY, INC.
Issuer CIK
1401667
Ticker
PBYI
Reporting person
Allison Dorval
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jun 11, 2026
Transaction code
A
Shares / units
27,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
102,390
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.